About AdvisorShares Psychedelics ETF (PSIL)

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that focuses on companies involved in the psychedelics industry. The fund seeks to track the performance of the AdvisorShares Psychedelics Index, which is designed to provide exposure to companies that are either engaged in or have the potential to benefit from the growing psychedelics industry. PSIL provides investors with a new way to participate in this emerging market, which has gained significant attention in recent years.

PSIL offers investors access to a diversified portfolio of companies that are involved in various aspects of the psychedelics industry. This includes companies that are researching, developing, or manufacturing psychedelics drugs, as well as those that are providing ancillary services or products to the industry. Some of the specific areas of focus for PSIL include drug discovery, clinical trials, medical applications, and technology solutions.